Antineoplastic Agent
From Anvita Health Wiki
More Specific Terms
- 1-(2-choloroethyl)-3-(2,5-dioxo-3-piperidyl)-1-nitrosourea (PCNU)
- 2-chlorodeoxyadenosine (2-CdA) [cladribine] (Leustatin)
- 5-fluorouracil [5-FU] (Fluoroplex, Efudex, Adrucel)
- 6-mercaptopurine (Purinethol, 6-MP, Mecaleukin, Leukerin, Leupurin)
- abarelix (Plenaxis)
- abiraterone acetate
- alemtuzumab (Campath-1H)
- alitretinoin (Panretin)
- alkylating agent combination
- altretamine (Hexalen)
- anastrozole (Arimidex)
- antibiotic antineoplastic agent
- antineoplaton
- arsenic trioxide; As2O3 (Trisenox)
- asparaginase (Elspar)
- azacitidine (Vidaza)
- Bacillus Calmette-Guerin (BCG, TheraCys, TICE, Pacis)
- belagenpumatucel-L (Lucanix)
- bevacizumab (Avastin)
- bexarotene (Targretin)
- bicalutamide (Casodex)
- bleomycin (Blenoxane)
- BMS-354825
- bortezomib (Velcade)
- brentuximab vedotin (Adcetris)
- buserelin (Suprecur)
- busulfan (Myleran)
- cabazitaxel
- capecitabine (Xeloda)
- carboplatin (CDBCA, Paraplatin)
- carmustine (BCNU, BiCNU, Carmubris)
- chlorambucil (Leukeran)
- cisplatin (Platinol)
- clofarabine (Clolar)
- crizotinib (Xalkori)
- cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271]
- cytosine arabinoside; cytarabine (Cytosar, ARA-C, HiDAC, Depocyt)
- dacarbazine (DTIC)
- dasatinib (Sprycel)
- daunorubicin, daunomycin; DNR (Cerubidine, DaunoXome)
- decitabine or 5-aza-2'-deoxycytidine
- degarelix
- denileukin diftitox (Ontak)
- docetaxel (Taxotere)
- doxorubicin (Adriamycin, Rubex)
- epirubicin; pidorubicin (Ellence)
- epothilone
- eribulin mesylate (Halaven)
- erlotinib (Tarceva)
- estramustine (Emcyt)
- etoposide (Vepesid, VP-16)
- everolimus (Afinitor)
- exemestane (Aromasin)
- flavopiridol
- floxuridine
- fludarabine (Fludara)
- flutamide (Eulexin, Niftholide)
- fulvestrant (Faslodex)
- GDC-0449
- gefitinib (Iressa)
- gemcitabine (Gemzar)
- gemtuzumab ozogamicin (Mylotarg)
- goserelin (Zoladex)
- gp100:209-217(210 M) peptide vaccine
- idarubicin; 4-methoxydaunorubicin (Idamycin)
- ifosfamide (Ifex, Friedman acid)
- imatinib (Gleevec)
- iniparib
- ipilimumab (Yervoy)
- irinotecan; camptothecin (Camptosar, Topotecin, CPT-11)
- ixabepilone (BMS-247550)
- lapatinib (Tykerb)
- lenalidomide (Revlimid)
- letrozole (Femara)
- leuprolide; leuprorelin (Lupron)
- levamisole (Ergamisole)
- lomustine (CCNU, CeeNU, Belustine)
- mechlorethamine; nitrogen mustard (Mustargen, Nor-mustard, Chlorethazine)
- melphalan (Alkeran, L-PAM, L-sarcolysin phenylalanine mustard)
- methotrexate (Rheumatrex, MTX)
- mitotane (Lysodren)
- mycophenolate (Cellcept, Myfortic)
- nelarabine (Arranon)
- nilotinib (Tasigna)
- nilutamide (Nilandron)
- nimustine (ACNU)
- nocodazole
- oblimersen (Bcl-2 antisense)
- ofatumumab (Arzerra)
- oxaliplatin
- paclitaxel (Taxol, Abraxane)
- pazopanib (Votrient)
- pegaspargase (Oncaspar, PEG-L-asparaginase)
- pemetrexed (Alimta, LY231514, Rolazar, Tifolar)
- pentostatin (Nipent, DCF, 2'deoxycoformycin)
- pertuzumab
- porfimer (Photofrin&trade)
- pralatrexate (Folotyn)
- procarbazine (Matulane, Natulan, ibenzmethyzin)
- raltitrexed (Tomudex)
- ranibizumab (Lucentis)
- ricin
- rituximab (Rituxin, Mabthera)
- romidepsin (Istodax)
- ruxolitinib
- semaxinib (SU5416)
- sirolimus; rapamycin (Rapamune)
- sorafenib (Nexavar)
- streptozocin (Zanosar)
- sunitinib (Sutent)
- temozolomide (Temodar, Methazolastone)
- temsirolimus (Torisel)
- teniposide (Vumon)
- testolactone (Teslac)
- tezosentan
- TG101348
- thioguanine
- thiotepa; thiophosphamide (Tespa, Thioplex)
- tirapazamine (TPZ)
- topotecan (Hycamtin, SKF-104864A, Topo, TPT)
- toremifene (Fareston)
- tositumomab (Bexxar)
- trastuzumab (Herceptin)
- tremelimumab
- triptorelin (Trelstar LA)
- valrubicin (Valstar)
- vandetanib (Caprelsa)
- vemurafenib (Zelboraf, PLX4032)
- vinblastine; vincaleukoblastine (Velban, Velsar, Alkaban-AQ)
- vincristine; 22-oxovincaleukoblastine; leurocristine (Oncovin, Vincasar PFS)
- vinorelbine (Navelbine)
- vorinostat (Zolinza, SAHA)
More General Terms
Additional Terms
References
- National Guideline Clearinghouse Guideline for classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. ngc-guideline: [1]
antineoplastic agent (chemotherapeutic agent)
